Inspired by the recent pandemic that made traditional clinical trial processes difficult, Bayer ran a proof-of-concept (POC) study that examined if Signant’s Virtual Monitoring served as a viable solution for replacing in-person site selection visits.

Read our case study to learn about how the digital tool stacked up against the traditional, in-person visits. Plus, we share details on the pilot design process, challenges, and the results.

For a demo or presentation, please contact our team.